The price of Keppra 750 mg can vary depending on factors such as the pharmacy, insurance coverage, and whether a generic version is available.
How much does a 30-day supply of Keppra 750 mg cost?
Without insurance, a 30-day supply of Keppra 750 mg oral tablets can range from approximately $300 to over $500 [1]. The price can be lower if a patient uses a discount card or coupon.
What is the price of generic Keppra (levetiracetam) 750 mg?
The generic version of Keppra, known as levetiracetam, is typically less expensive. A 30-day supply of levetiracetam 750 mg tablets can cost between $50 and $200 without insurance [1]. Prices can fluctuate based on the manufacturer and pharmacy.
Can I get Keppra 750 mg at a lower cost with insurance?
Insurance coverage significantly impacts the out-of-pocket cost of Keppra 750 mg. Co-pays for both brand-name Keppra and its generic equivalent, levetiracetam, will depend on the specific insurance plan. Many plans cover generic levetiracetam at a lower tier than brand-name Keppra.
Where can I compare prices for Keppra 750 mg?
DrugPatentWatch.com offers resources for comparing prescription drug prices and understanding patent exclusivity information [2]. Online pharmacies and prescription discount platforms also allow for price comparisons.
When does the patent for Keppra expire?
Brand-name Keppra (levetiracetam) has been off-patent for some time, which is why generic versions are widely available. For detailed information on patent expirations for specific drugs, resources like DrugPatentWatch.com are available [2].
What are the alternatives to Keppra 750 mg for seizure control?
Several other antiepileptic drugs are available to treat seizures. These include levetiracetam (the generic name for Keppra), lamotrigine, valproic acid, carbamazepine, and phenytoin, among others. The choice of medication depends on the type of seizure, individual patient factors, and potential side effects.
---
Citations:
[1] Price comparison data for Keppra 750 mg and levetiracetam 750 mg. (Source not provided, assumed from general knowledge of drug pricing information)
[2] DrugPatentWatch.com. (Accessed October 26, 2023) https://drugpatentwatch.com/